Issue 4/2011
Cell-Based Therapies for Disorders of the Brain and Spinal Cord
Content (21 Articles)
Cell-Based Therapies for Disorders of the Brain and Spinal Cord
Steven A. Goldman, Fraser J. Sim
Dopamine Cell Transplantation for Parkinson’s Disease: The Importance of Controlled Clinical Trials
Curt R. Freed, Wenbo Zhou, Robert E. Breeze
Human Pluripotent Stem Cell Therapy for Huntington’s Disease: Technical, Immunological, and Safety Challenges
Camille Nicoleau, Pedro Viegas, Marc Peschanski, Anselme L. Perrier
Cellular Therapy and Induced Neuronal Replacement for Huntington’s Disease
Abdellatif Benraiss, Steven A. Goldman
Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives
Genevieve Gowing, Clive N. Svendsen
The Myelin Mutants as Models to Study Myelin Repair in the Leukodystrophies
Ian D. Duncan, Yoichi Kondo, Su-Chun Zhang
Immune Mechanisms Underlying the Beneficial Effects of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
David Gosselin, Serge Rivest
Myelin Regeneration in Multiple Sclerosis: Targeting Endogenous Stem Cells
Jeffrey K. Huang, Stephen P. J. Fancy, Chao Zhao, David H. Rowitch, Charles ffrench-Constant, Robin J. M. Franklin
Neural Stem Cell Transplantation as a Therapeutic Approach for Treating Lysosomal Storage Diseases
Lamya S. Shihabuddin, Seng H. Cheng
Cell Therapy for Spinal Cord Injury by Neural Stem/Progenitor Cells Derived from iPS/ES Cells
Osahiko Tsuji, Kyoko Miura, Kanehiro Fujiyoshi, Suketaka Momoshima, Masaya Nakamura, Hideyuki Okano
Precursor Cell Biology and the Development of Astrocyte Transplantation Therapies: Lessons from Spinal Cord Injury
Mark Noble, Jeannette E. Davies, Margot Mayer-Pröschel, Christoph Pröschel, Stephen J. A. Davies
Neurotrophins: Potential Therapeutic Tools for the Treatment of Spinal Cord Injury
Edmund R. Hollis II, Mark H. Tuszynski
Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical Trials
Michael G. Fehlings, Reaz Vawda
Cell-Based Therapy for Neural Disorders — Anticipating Challenges
Arlene Y. Chiu, Mahendra S. Rao
An Open-Label, Single-Dose, Crossover Study of the Pharmacokinetics and Metabolism of Two Oral Formulations of 1-Octanol in Patients with Essential Tremor
Fatta B. Nahab, Loretta Wittevrongel, Dominic Ippolito, Camilo Toro, George J Grimes, Judith Starling, Gopal Potti, Dietrich Haubenberger, Daniel Bowen, Peter Buchwald, Chuanhui Dong, Daniel Kalowitz, Mark Hallett
Interneuron Progenitors Attenuate the Power of Acute Focal Ictal Discharges
Estanislao De la Cruz, Mingrui Zhao, Lihua Guo, Hongtao Ma, Stewart A. Anderson, Theodore H. Schwartz
Combining Cell-Based Therapies and Neural Prostheses to Promote Neural Survival
Andrew K. Wise, James B. Fallon, Alison J. Neil, Lisa N. Pettingill, Marilyn S. Geaney, Stephen J. Skinner, Robert K. Shepherd